Citation Impact
Citing Papers
Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands
2020
Merging cultures in the study of membrane traffic
2004 StandoutNobel
Neurologic Complications of the Reactivation of Varicella–Zoster Virus
2000 Standout
Influenza virus M2 protein has ion channel activity
1992
A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment
1995 Standout
Studies of Proton Translocations in Biological Systems: Simulating Proton Transport in Carbonic Anhydrase by EVB-Based Models
2004 StandoutNobel
What Really Prevents Proton Transport through Aquaporin? Charge Self-Energy versus Proton Wire Proposals
2003 StandoutNobel
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis
2008 StandoutNobel
Recognition-mediated activation of therapeutic gold nanoparticles inside living cells
2010
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
1991 Standout
Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: comparison between normotensive and spontaneously hypertensive rats
2001
Antiviral agents active against influenza A viruses
2006
An application of prefrontal cortex function theory to cognitive aging.
1996 Standout
Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170)
1989 StandoutNobel
Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis
1987
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
HIV infection does not require endocytosis of its receptor, CD4
1988 StandoutNobel
Do Vpu and Vpr of Human Immunodeficiency Virus Type 1 and NB of Influenza B Virus Have Ion Channel Activities in the Viral Life Cycles?
1997
Molecular mechanism and physiological functions of clathrin-mediated endocytosis
2011 Standout
Non-motor features of Parkinson disease
2017 Standout
On the origin of the electrostatic barrier for proton transport in aquaporin
2004 StandoutNobel
Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
1995
Unusual architecture of the p7 channel from hepatitis C virus
2013 Nature
The Pathobiology of Vascular Dementia
2013 Standout
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
1996 StandoutNature
Nuclear Import of Influenza Virus RNA Can Be Mediated by Viral Nucleoprotein and Transport Factors Required for Protein Import
1995 StandoutNobel
Ionic-Liquid-Mediated Extraction and Separation Processes for Bioactive Compounds: Past, Present, and Future Trends
2017 Standout
RNA virus evolution and the control of viral disease
1989
Voltage-Gated Proton Channels and Other Proton Transfer Pathways
2003
A Comvewiemt Synthesis of 1-Aminopolycycloalkames and Their Tosylate Salts
1988
Chemistry of Polyvalent Iodine
2008 Standout
Palladium-catalyzed methylene C(sp3)–H arylation of the adamantyl scaffold
2015
Post-mortem distribution of dopamine and homo-vanillic acid in human brain, variations related to age, and a review of the literature
1979
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
1986 StandoutNobel
The effect of a carbobenzoxy tripeptide on the biological activities of measles virus
1971
Infectious entry pathway of influenza virus in a canine kidney cell line.
1981
9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group
1978 StandoutNatureNobel
Species differences in the disposition of acyclovir
1982 StandoutNobel
Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin.
1982
A review of cancer cachexia and abnormal glucose metabolism in humans with cancer.
1992
Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes.
1992 StandoutNobel
Palladium-Catalyzed Transformations of Alkyl C–H Bonds
2016 Standout
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.
1978 StandoutNobel
Endocytosis and the recycling of plasma membrane.
1983 StandoutNobel
Organic Polyvalent Iodine Compounds
1996 Standout
Nucteotide sequence of human influenza A/PR/8/34 segment 2
1982 StandoutNobel
Frontotemporal lobar degeneration
1998 Standout
Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin
2000 Standout
Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate
1979 StandoutNobel
Effect of Acycloguanosine Treatment on Acute and Latent Herpes Simplex Infections in Mice
1979 StandoutNobel
Initial Stages in Infection with Animal Viruses
1982
Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer
1978
Inhibition of Semliki Forest Virus Penetration by Lysosomotropic Weak Bases
1982
?Striato-nigrale Degeneration?
1968
Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function.
1981 StandoutNobel
Early events in cell-animal virus interactions
1973
In vitro susceptibility of varicella-zoster virus to acyclovir
1980 StandoutNobel
Scanning the Potential Energy Surface for Synthesis of Dendrimer-Wrapped Gold Clusters: Design Rules for True Single-Molecule Nanostructures
2012 StandoutNobel
Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice
1982 StandoutNobel
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Surface distribution and recycling of the low density lipoprotein receptor as visualized with antireceptor antibodies.
1982 StandoutNobel
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry
2006 StandoutNobel
On the entry of semliki forest virus into BHK-21 cells
1980
Lysosomotropic agents
1974 StandoutNobel
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Mechanism of action and selectivity of acyclovir
1982 StandoutNobel
Influenza Virus Genetics
1979
Responsibility of extrastriatal areas for the appearance of psychotic symptoms (Clinical and biochemical human post-mortem findings)
1975
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Time course of nigrostriatal degeneration in parkinson's disease
1976
Proton-Coupled Electron Transfer
2012 Standout
Metabolism of acyclovir in virus-infected and uninfected cells
1981 StandoutNobel
Inhibition of cellular alpha and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir
1980 StandoutNobel
Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication
1980 StandoutNobel
Works of E Neumayer being referenced
[L-tryptophan therapy of DOPA psychoses].
1972
Progressive subcorticale vascul�re Encephalopathie Binswanger
1964
Das Lactat-Pyruvat-Verh�ltnis im Blut bei Patienten mit einem Larynxcarcinom
1967
Die moderne medikament�se Behandlung des Parkinsonismus
1972
The balance of biogenic amines as condition for normal behaviour
1972
Mode of Action of the Antiviral Activity of Amantadine in Tissue Culture
1965
[Modern treatment of parkinsonism].
1972
The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depressionsyndrom
1974
Antiviral Activity of 1-Adamantanamine (Amantadine)
1964 Science
Angiodysgenetische nekrotisierende Myelopathie
1968
Antiviral Activity of Amantadine Hydrochloride in Tissue Culture and in ovo.
1965
[A chorea kinship with rigid form].
1966
Longevity in Parkinson's disease treated with L-DOPA
1974
Nucleus ruber and L-Dopa psychosis: Biochemical post-mortem findings
1974